digiM
Pharmaceutical ManufacturingMassachusetts, United States11-50 Employees
We provide advanced 3D microstructure analysis insights that predict product quality and performance to accelerate your pharmaceutical development and regulatory success.
Innovation in Pharma DigiM specializes in advanced 3D microstructure analysis that enhances product quality and performance prediction, creating opportunities to collaborate with pharmaceutical companies seeking to optimize their drug development and regulatory approval processes.
Growth in Digital Security With recent financial reports highlighting growth in recurring revenue and successful trials of secure gift card solutions, DigiM presents potential for expanding into retail and anti-counterfeiting markets that value digital authentication technologies.
Market Expansion Opportunities DigiM's involvement in digital identity and authentication solutions, combined with its strategic participation in industry conferences, positions the company to capitalize on increasing demand for secure digital solutions across various sectors including retail, healthcare, and logistics.
Technological Edge The company's adoption of a robust tech stack and focus on innovative solutions like digital watermarks and anti-counterfeiting tools makes it an attractive partner for clients seeking cutting-edge security and integrity systems.
Financial Turnaround DigiM's recent achievement of positive free cash flow and improved margins signals a strengthening financial position, offering sales teams the opportunity to promote their solutions to clients looking for reliable, financially stable partners in high-growth sectors.
digiM uses 8 technology products and services including Site Kit, HubSpot Analytics, WordPress, and more. Explore digiM's tech stack below.
| digiM Email Formats | Percentage |
| First.Last@digimsolution.com | 100% |
Pharmaceutical ManufacturingMassachusetts, United States11-50 Employees
We provide advanced 3D microstructure analysis insights that predict product quality and performance to accelerate your pharmaceutical development and regulatory success.
digiM's revenue is estimated to be in the range of $25M$50M
digiM's revenue is estimated to be in the range of $25M$50M